70 related articles for article (PubMed ID: 19759112)
1. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H
J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112
[TBL] [Abstract][Full Text] [Related]
2. The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Walentowicz-Sadlecka M; Malkowski B; Walentowicz P; Sadlecki P; Marszalek A; Pietrzak T; Grabiec M
Biomed Res Int; 2014; 2014():234813. PubMed ID: 24719847
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
Munter-Young R; Fuentes-Alburo A; DiGregorio N; Neeser K; Gultyaev D
PLoS One; 2024; 19(5):e0302486. PubMed ID: 38743917
[TBL] [Abstract][Full Text] [Related]
4. Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Fowler AM; Chan SR; Sharp TL; Fettig NM; Zhou D; Dence CS; Carlson KE; Jeyakumar M; Katzenellenbogen JA; Schreiber RD; Welch MJ
J Nucl Med; 2012 Jul; 53(7):1119-26. PubMed ID: 22669982
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Analysis of [
Ghazanfari N; Doorduin J; van der Weijden CWJ; Willemsen ATM; Glaudemans AWJM; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2024 Apr; 26(2):351-359. PubMed ID: 38263484
[TBL] [Abstract][Full Text] [Related]
6.
Grabher BJ
J Nucl Med Technol; 2023 Sep; 51(3):188-193. PubMed ID: 37433673
[TBL] [Abstract][Full Text] [Related]
7. Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.
Berg A; Gulati A; Ytre-Hauge S; Fasmer KE; Mauland KK; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Stefansson I; Akslen LA; Woie K; Bjørge L; Salvesen HB; Salvesen ØO; Werner HMJ; Haldorsen IS; Krakstad C
Oncotarget; 2017 Sep; 8(40):68530-68541. PubMed ID: 28978135
[TBL] [Abstract][Full Text] [Related]
8. 17-β-estradiol reduces surface PD-L1 expression in estrogen receptor-positive breast cancer but not type 1 endometrial cancer cells.
Li H; Gu W; Jeffery P; Chen C
Clin Transl Med; 2023 Jul; 13(7):e1330. PubMed ID: 37448208
[No Abstract] [Full Text] [Related]
9. Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging.
Bonaventura J; Boehm MA; Jedema HP; Solis O; Pignatelli M; Song X; Lu H; Richie CT; Zhang S; Gomez JL; Lam S; Morales M; Gharbawie OA; Pomper MG; Stein EA; Bradberry CW; Michaelides M
Sci Transl Med; 2023 Jul; 15(706):eadd1014. PubMed ID: 37494470
[TBL] [Abstract][Full Text] [Related]
10.
Duran C; Ward RC; Dibble EH
Clin Breast Cancer; 2024 Feb; ():. PubMed ID: 38548518
[No Abstract] [Full Text] [Related]
11. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.
Vahidfar N; Farzanefar S; Ahmadzadehfar H; Molloy EN; Eppard E
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406552
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of 16α-
Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation of residual tumor in patients with endometrial carcinoma by using
Wu C; Chen R; Zhou X; Xia Q; Liu J
J Cancer; 2020; 11(8):2283-2288. PubMed ID: 32127955
[No Abstract] [Full Text] [Related]
14. Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.
Espedal H; Fonnes T; Fasmer KE; Krakstad C; Haldorsen IS
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783595
[TBL] [Abstract][Full Text] [Related]
15. What's New in Imaging for Gynecologic Cancer?
Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510
[TBL] [Abstract][Full Text] [Related]
17. Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer
Paquette M; Lavallée É; Phoenix S; Ouellet R; Senta H; van Lier JE; Guérin B; Lecomte R; Turcotte ÉE
J Nucl Med; 2018 Feb; 59(2):197-203. PubMed ID: 28798032
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
[TBL] [Abstract][Full Text] [Related]
19. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
[TBL] [Abstract][Full Text] [Related]
20. Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
Kitajima K; Ebina Y; Sugimura K
Jpn J Radiol; 2014 Jun; 32(6):313-23. PubMed ID: 24744135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
